Buccal drug administration in the treatment of female sexual dysfunction
OwnerVirgil A. Placeinventor
Life of this patent
Estimating the term…
Abstract
A buccal dosage unit is provided for administering a combination of steroidal active agents to a female individual. The novel buccal drug delivery systems may be used in female hormone replacement therapy, in female contraception, to treat female sexual dysfunction, and to treat or prevent a variety of conditions and disorders which are responsive to the active agents discussed herein. The buccal dosage unit comprises a progestin, an estrogen and optionally an androgenic agent, as well as a polymeric carrier that bioerodes and provides for delivery of the active agents throughout a predetermined drug delivery period.
Claims40
A method for treating sexual dysfunction in a female individual, comprising buccally administering a combination of steroidal active agents to an individual in need of such treatment, wherein administration is carried out by (a) providing a buccal dosage unit comprised of a compressed tablet of a bioerodible polymeric carrier and therapeutically effective amounts of an androgenic agent, a progestin and an estrogen;
- and (b) affixing the dosage unit to the buccal mucosa of the individual and allowing the dosage unit to remain in place until erosion thereof is complete.
A method for treating sexual dysfunction in a female individual, comprising buccally administering a combination of steroidal active agents to an individual in need of such treatment, wherein administration is carried out by (a) providing a buccal dosage unit comprised of a compressed tablet of a bioerodible polymeric carrier and therapeutically effective amounts of a progestin and an estrogen;
- and (b) affixing the dosage unit to the buccal mucosa of the individual and allowing the dosage unit to remain in place until erosion thereof is complete.
Dependencies are inferred from the claim text.